Search for: "Novo Nordisk A/S"
Results 201 - 220
of 310
Sorted by Relevance
|
Sort by Date
26 Sep 2023, 4:49 am
Novo Nordisk A/S. [read post]
26 Sep 2023, 4:49 am
Novo Nordisk A/S. [read post]
7 Dec 2023, 11:17 am
This appointment positions Buchanan at the forefront of a critical legal battle against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi – who control nearly the entire U.S. insulin market – as well as the nation’s three largest pharmacy benefit managers (PBMs), CVS Caremark, Express Scripts, and OptumRx, over allegations these companies used unlawful, unfair, and deceptive practices to aggressively hike the cost of insulin and other diabetes… [read post]
27 Jun 2011, 8:41 am
Novo Nordisk A/S Docket: 10-844 Issue(s): Whether the counterclaim provision of the Hatch-Waxman Act applies when (1) there is “an approved method of using the drug” that “the patent does not claim,” and (2) the brand submits “patent information” to the FDA that misstates the patent’s scope, requiring “correct[ion]. [read post]
29 Dec 2010, 2:57 am
Sandoz, Inc (IPBiz) (Patent Docs) Plavix (Clopidogrel) – Brazil: Superior Court of Justice denies Plavix patent extension (IP tango) Prandin (Repaglinide) – US: Novo Nordisk and Sandoz settle infringement claims in Prandin dispute (Patent Docs) Prandin (Repaglinide) – US: Supreme Court petitioned to review Federal Circuit patent use code decision: Caraco v Novo Nordisk (FDA Law Blog) [read post]
22 Apr 2010, 3:51 am
Teva (Orange Book Blog) (FDA Law Blog) Levistra (Vardenafil) – US: District Court Delaware: Patent infringement complaint following ANDA filing: Bayer Schering Pharma AG et al v Teva Pharmaceuticals USA, Inc et al (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for infringement of Nexavar patent before Delhi High Court (Spicy IP) Norfloxacin – Canada: Federal Court: Judgment in s 8 proceeding: Apotex v Merck (Pharmacapsules) Prandin (Repaglinide) – US:… [read post]
28 Nov 2019, 12:57 pm
The case related to GSK’s European patent EP 1965823, which was opposed by Sanofi, Novo Nordisk, Generics Ltd and Eli Lilly. [read post]
28 Jul 2013, 9:29 am
Some of the other diabetes drugs being investigated include Bydureon and Onglyza, sold by Bristol-Myers Squibb; AstraZeneca and Victoza from Novo Nordisk; Tradjenta from Eli Lilly and Boehringer Ingelheim; and Nesina from Takeda. [read post]
5 Dec 2011, 5:46 am
Novo Nordisk A/S (10-844) and Messerschmidt v. [read post]
29 Jun 2011, 5:59 am
Novo Nordisk A/S is a case involving a particular aspect of the Hatch-Waxman Act as pertaining to pharmaceutical approval. [read post]
15 May 2019, 6:42 am
” Witnesses at the hearing included Eli Lilly, Novo Nordisk, Sanofi, Cigna’s Express Scripts, United Healthcare’s Optum, and CVS. [read post]
23 Mar 2011, 9:55 am
Novo Nordisk, A/S, 108 F.3d 1361, 1364 (Fed. [read post]
2 Mar 2012, 9:10 am
Victoza manufacturer Novo Nordisk says that weight loss is just one of the many “beneficial” side effects of the drug. [read post]
6 Jul 2011, 10:52 am
Novo Nordisk A/S (Docket No. 10-844). [read post]
1 Jun 2008, 5:08 pm
Novo Nordisk Pharmaceutical Industries, Inc. v. [read post]
10 Mar 2023, 2:34 pm
Three months before those filings, the EEOC sued another pharmaceutical firm, Novo Nordisk, for ADEA violations. [read post]
27 May 2011, 8:56 am
Novo Nordisk A/S . [read post]
29 Sep 2011, 9:06 pm
Novo Nordisk, A/S, 108 F.3d 1361, 1364 (Fed. [read post]
5 Mar 2024, 10:55 am
For example, Novo Nordisk has issued three notices of correction for Ozempic since 2022; Eli Lilly has issued five for Cialis and six for Strattera since 2021. [read post]
14 Nov 2023, 5:16 am
Meanwhile, the registry also indicates that the company Novo Nordisk, based in Germany, is also performing a late stage trial of the drug semaglutide, which is sold under the brand name Ozempic in kids who are only 6 years old. [read post]
